InvestorsHub Logo
Followers 82
Posts 6647
Boards Moderated 0
Alias Born 02/03/2018

Re: Number sleven post# 386104

Friday, 08/12/2022 8:17:21 PM

Friday, August 12, 2022 8:17:21 PM

Post# of 423966
Sleven - I think people are making this seem more complicated than it is. Companies have successfully protected their market exclusivity, by coming out with a "more convenient formulation."
Doctors are focused on price yes, but also compliance to the same degree, "if not more." Someone give me one example where a brand went from 4 horse pills to one, and from twice a day to once a day? I don't believe it exists. Now, are we to believe filling four caps is cheaper than filling one?

We have a homerun here. Big time. Let the Generics keep all it's customers on ice. When Amrn launches the single pill daily dose, all those customers will switch over. People want the best option, and they will ask for it when it's known that it exists.

ILT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News